18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Are environmental exposures from the World Trade Center disaster site associated with multiple myeloma and its precursor disease, monoclonal gammopathy of undetermined significance (MGUS), in New York City firefighters?

          Findings

          In this case series, 16 participants were diagnosed with multiple myeloma after September 11, 2001, with a median age of disease onset of 57 years, and in subsets with relevant data, a high proportion of the cases had light-chain myeloma, and plasma cells were CD20 positive. In the screening study, World Trade Center exposure was found to be statistically significantly associated with light-chain MGUS and overall MGUS.

          Meaning

          World Trade Center disaster exposures are associated with myeloma precursor disease (MGUS) and may be a risk factor for the development of multiple myeloma at an earlier age.

          Abstract

          This case series assesses whether environmental exposures from the World Trade Center disaster site are associated with multiple myeloma and its precursor disease, monoclonal gammopathy of undetermined significance, in New York City firefighters.

          Abstract

          Importance

          The World Trade Center (WTC) attacks on September 11, 2001, created an unprecedented environmental exposure to known and suspected carcinogens suggested to increase the risk of multiple myeloma. Multiple myeloma is consistently preceded by the precursor states of monoclonal gammopathy of undetermined significance (MGUS) and light-chain MGUS, detectable in peripheral blood.

          Objective

          To characterize WTC-exposed firefighters with a diagnosis of multiple myeloma and to conduct a screening study for MGUS and light-chain MGUS.

          Design, Setting, and Participants

          Case series of multiple myeloma in firefighters diagnosed between September 11, 2001, and July 1, 2017, together with a seroprevalence study of MGUS in serum samples collected from Fire Department of the City of New York (FDNY) firefighters between December 2013 and October 2015. Participants included all WTC-exposed FDNY white, male firefighters with a confirmed physician diagnosis of multiple myeloma (n = 16) and WTC-exposed FDNY white male firefighters older than 50 years with available serum samples (n = 781).

          Exposures

          WTC exposure defined as rescue and/or recovery work at the WTC site between September 11, 2001, and July 25, 2002.

          Main Outcomes and Measures

          Multiple myeloma case information, and age-adjusted and age-specific prevalence rates for overall MGUS (ie, MGUS and light-chain MGUS), MGUS, and light-chain MGUS.

          Results

          Sixteen WTC-exposed white male firefighters received a diagnosis of multiple myeloma after September 11, 2001; median age at diagnosis was 57 years (interquartile range, 50-68 years). Serum/urine monoclonal protein isotype/free light-chain data were available for 14 cases; 7 (50%) had light-chain multiple myeloma. In a subset of 7 patients, myeloma cells were assessed for CD20 expression; 5 (71%) were CD20 positive. In the screening study, we assayed peripheral blood from 781 WTC-exposed firefighters. The age-standardized prevalence rate of MGUS and light-chain MGUS combined was 7.63 per 100 persons (95% CI, 5.45-9.81), 1.8-fold higher than rates from the Olmsted County, Minnesota, white male reference population (relative rate, 1.76; 95% CI, 1.34-2.29). The age-standardized prevalence rate of light-chain MGUS was more than 3-fold higher than in the same reference population (relative rate, 3.13; 95% CI, 1.99-4.93).

          Conclusions and Relevance

          Environmental exposure to the WTC disaster site is associated with myeloma precursor disease (MGUS and light-chain MGUS) and may be a risk factor for the development of multiple myeloma at an earlier age, particularly the light-chain subtype.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: not found
          • Article: not found

          Multiple myeloma.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Estimation of a common effect parameter from sparse follow-up data.

            Breslow (1981, Biometrika 68, 73-84) has shown that the Mantel-Haenszel odds ratio is a consistent estimator of a common odds ratio in sparse stratifications. For cohort studies, however, estimation of a common risk ratio or risk difference can be of greater interest. Under a binomial sparse-data model, the Mantel-Haenszel risk ratio and risk difference estimators are consistent in sparse stratifications, while the maximum likelihood and weighted least squares estimators are biased. Under Poisson sparse-data models, the Mantel-Haenszel and maximum likelihood rate ratio estimators have equal asymptotic variances under the null hypothesis and are consistent, while the weighted least squares estimators are again biased; similarly, of the common rate difference estimators the weighted least squares estimators are biased, while the estimator employing "Mantel-Haenszel" weights is consistent in sparse data. Variance estimators that are consistent in both sparse data and large strata can be derived for all the Mantel-Haenszel estimators.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Health and environmental consequences of the world trade center disaster.

              The attack on the World Trade Center (WTC) created an acute environmental disaster of enormous magnitude. This study characterizes the environmental exposures resulting from destruction of the WTC and assesses their effects on health. Methods include ambient air sampling; analyses of outdoor and indoor settled dust; high-altitude imaging and modeling of the atmospheric plume; inhalation studies of WTC dust in mice; and clinical examinations, community surveys, and prospective epidemiologic studies of exposed populations. WTC dust was found to consist predominantly (95%) of coarse particles and contained pulverized cement, glass fibers, asbestos, lead, polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and polychlorinated furans and dioxins. Airborne particulate levels were highest immediately after the attack and declined thereafter. Particulate levels decreased sharply with distance from the WTC. Dust pH was highly alkaline (pH 9.0-11.0). Mice exposed to WTC dust showed only moderate pulmonary inflammation but marked bronchial hyperreactivity. Evaluation of 10,116 firefighters showed exposure-related increases in cough and bronchial hyperreactivity. Evaluation of 183 cleanup workers showed new-onset cough (33%), wheeze (18%), and phlegm production (24%). Increased frequency of new-onset cough, wheeze, and shortness of breath were also observed in community residents. Follow-up of 182 pregnant women who were either inside or near the WTC on 11 September showed a 2-fold increase in small-for-gestational-age (SGA) infants. In summary, environmental exposures after the WTC disaster were associated with significant adverse effects on health. The high alkalinity of WTC dust produced bronchial hyperreactivity, persistent cough, and increased risk of asthma. Plausible causes of the observed increase in SGA infants include maternal exposures to PAH and particulates. Future risk of mesothelioma may be increased, particularly among workers and volunteers exposed occupationally to asbestos. Continuing follow-up of all exposed populations is required to document the long-term consequences of the disaster.
                Bookmark

                Author and article information

                Journal
                JAMA Oncol
                JAMA Oncol
                JAMA Oncol
                JAMA Oncology
                American Medical Association
                2374-2437
                2374-2445
                26 April 2018
                June 2018
                26 April 2018
                : 4
                : 6
                : 821-827
                Affiliations
                [1 ]Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
                [2 ]Department of Medicine, Montefiore Medical Center, Bronx, New York
                [3 ]Bureau of Health Services, Fire Department of the City of New York, Brooklyn, New York
                [4 ]Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
                [5 ]Division of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
                [6 ]Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
                [7 ]Department of Hematopathology, Memorial Sloan Kettering Cancer Center, New York, New York
                [8 ]Division of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
                [9 ]Mount Sinai School of Medicine, New York, New York
                [10 ]Department of Medicine, Division of Pulmonary Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, New York, New York
                Author notes
                Article Information
                Accepted for Publication: February 5, 2018.
                Published Online: April 26, 2018. doi:10.1001/jamaoncol.2018.0509
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2018 Landgren O et al. JAMA Oncology.
                Corresponding Author: Ola Landgren, MD, PhD, Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065 ( landgrec@ 123456mskcc.org ).
                Author Contributions: Drs Zeig-Owens and Prezant had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Landgren, Zeig-Owens, Giricz, Verma, and Prezant contributed equally.
                Study concept and design: Landgren, Zeig-Owens, Giricz, Steidl, Hall, Cohen, Webber, Verma, Prezant.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Landgren, Zeig-Owens, Goldfarb, Crane, Irby, Webber, Verma.
                Critical revision of the manuscript for important intellectual content: Landgren, Giricz, Goldfarb, Murata, Thoren, Ramanathan, Hultcrantz, Dogan, Nwankwo, Steidl, Pradhan, Hall, Cohen, Jaber, Schwartz, Crowley, Webber, Verma, Prezant.
                Statistical analysis: Zeig-Owens, Giricz, Goldfarb, Hultcrantz, Pradhan, Hall, Jaber, Schwartz, Verma.
                Obtained funding: Landgren, Hall, Webber, Verma, Prezant.
                Administrative, technical, or material support: Landgren, Giricz, Murata, Ramanathan, Dogan, Nwankwo, Jaber, Crane, Verma, Prezant.
                Study supervision: Landgren, Zeig-Owens, Giricz, Steidl, Hall, Webber, Prezant.
                Conflict of Interest Disclosures: None reported.
                Funding/Support: This study was supported by the V Foundation for Cancer Research, the Byrne Fund for the benefit of Memorial Sloan-Kettering, the Memorial Sloan Kettering Cancer Center Core Grant from the National Cancer Institute (P30 CA008748), the Albert Einstein Cancer Center (P30 CA013330), and the National Institute for Occupational Safety and Health (grant 1 U01 OH011475 and contracts 200-2011-39383, 200-2011-39378, 200-2017-93326, and 200-2017-93426).
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Article
                coi180017
                10.1001/jamaoncol.2018.0509
                6145680
                29710195
                13e0a454-3b95-44d4-88ac-7d8bfd3e62b5
                Copyright 2018 Landgren O et al. JAMA Oncology.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 30 November 2017
                : 2 February 2018
                : 5 February 2018
                Funding
                Funded by: V Foundation for Cancer Research
                Funded by: Byrne Fund for the benefit of Memorial Sloan-Kettering
                Funded by: Memorial Sloan Kettering Cancer Center Core Grant from the National Cancer Institute
                Funded by: Albert Einstein Cancer Center
                Funded by: National Institute for Occupational Safety and Health
                Categories
                Research
                Research
                Original Investigation
                Featured
                Online First

                Comments

                Comment on this article